• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: potassium-competitive acid blockers for acid-related diseases-tegoprazan, a new kid on the block.

作者信息

Scarpignato Carmelo, Hunt Richard H

机构信息

Faculty of Medical Sciences, LUdeS Lugano Campus, Lugano, Switzerland.

United Campus of Malta, Msida, Malta.

出版信息

Aliment Pharmacol Ther. 2019 Oct;50(8):960-962. doi: 10.1111/apt.15480.

DOI:10.1111/apt.15480
PMID:31591775
Abstract
摘要

相似文献

1
Editorial: potassium-competitive acid blockers for acid-related diseases-tegoprazan, a new kid on the block.社论：用于酸相关疾病的钾竞争性酸阻滞剂——替戈拉赞，该领域的新成员。
Aliment Pharmacol Ther. 2019 Oct;50(8):960-962. doi: 10.1111/apt.15480.
2
Tegoprazan, a Novel Potassium-Competitive Acid Blocker to Control Gastric Acid Secretion and Motility.替戈拉赞，一种新型钾离子竞争性酸阻滞剂，用于控制胃酸分泌和运动。
J Pharmacol Exp Ther. 2018 Feb;364(2):275-286. doi: 10.1124/jpet.117.244202. Epub 2017 Nov 27.
3
Effects of Tegoprazan, a Novel Potassium-Competitive Acid Blocker, on Rat Models of Gastric Acid-Related Disease.替戈拉赞（一种新型钾离子竞争性酸阻滞剂）对胃酸相关疾病大鼠模型的影响。
J Pharmacol Exp Ther. 2019 Jun;369(3):318-327. doi: 10.1124/jpet.118.254904. Epub 2019 Mar 20.
4
Editorial: tegoprazan-the newest advance in the management of acid-related diseases.
Aliment Pharmacol Ther. 2020 Sep;52(6):1074-1075. doi: 10.1111/apt.15963.
5
Pharmacodynamics of tegoprazan and revaprazan after single and multiple oral doses in healthy subjects.健康受试者中单次和多次口服替戈拉赞和雷贝拉唑后的药效动力学。
Aliment Pharmacol Ther. 2020 Dec;52(11-12):1640-1647. doi: 10.1111/apt.16121. Epub 2020 Nov 1.
6
Simultaneous quantification of tegoprazan and its major metabolite M1 in dog plasma using liquid chromatography-tandem mass spectrometry.采用液相色谱-串联质谱法同时定量测定犬血浆中的替戈拉赞及其主要代谢物 M1。
J Pharm Biomed Anal. 2019 Jul 15;171:99-103. doi: 10.1016/j.jpba.2019.03.045. Epub 2019 Mar 21.
7
Editorial: pharmacodynamics of potassium-competitive acid blockers: comparing apples with apples-and with oranges.社论：钾竞争性酸阻滞剂的药效学：同类相比——以及异类相比。
Aliment Pharmacol Ther. 2021 Jan;53(1):190-191. doi: 10.1111/apt.16140.
8
Editorial: pharmacodynamics of potassium-competitive acid blockers: comparing apples with apples - and with oranges. Authors' reply.编者按：钾离子竞争性酸阻滞剂的药效学：同类相比——及与异类相比。作者回复
Aliment Pharmacol Ther. 2021 Jan;53(1):192-193. doi: 10.1111/apt.16165.
9
The first case of tegoprazan-induced urticaria.首例替戈拉赞导致的荨麻疹。
J Clin Pharm Ther. 2020 Oct;45(5):1187-1189. doi: 10.1111/jcpt.13150. Epub 2020 Jun 29.
10
Tetrahydrochromenoimidazoles as potassium-competitive acid blockers (P-CABs): structure-activity relationship of their antisecretory properties and their affinity toward the hERG channel.四氢色烯并咪唑作为钾离子竞争性酸阻滞剂 (P-CABs)：其抗分泌性质和对 hERG 通道亲和力的构效关系。
J Med Chem. 2010 May 13;53(9):3645-74. doi: 10.1021/jm100040c.

引用本文的文献

1
Diagnosis and Management of Gastroesophageal Reflux Disease: Current Insights.胃食管反流病的诊断与管理：当前见解
Clin Exp Gastroenterol. 2025 Jul 8;18:149-162. doi: 10.2147/CEG.S507237. eCollection 2025.
2
[History and Pharmacological Mechanism of Gastric Acid-suppressive Drugs].[胃酸抑制药物的历史与药理机制]
Korean J Helicobacter Up Gastrointest Res. 2023 Sep;23(3):159-166. doi: 10.7704/kjhugr.2023.0040. Epub 2023 Sep 8.
3
Comparison of Tegoprazan and Lansoprazole in Patients With Erosive Esophagitis up to 4 Weeks: A Multi-Center, Randomized, Double-Blind, Active-Comparator Phase 4 Trial.
替戈拉赞与兰索拉唑治疗糜烂性食管炎长达4周的比较：一项多中心、随机、双盲、活性对照4期试验。
Neurogastroenterol Motil. 2025 Jan;37(1):e14969. doi: 10.1111/nmo.14969. Epub 2024 Nov 25.
4
RETRACTED: A Phase III Head-to-Head Study to Compare the Efficacy and Safety of Fexuprazan and Esomeprazole in Treating Patients with Erosive Esophagitis.撤回：一项比较非布司他和埃索美拉唑治疗糜烂性食管炎疗效和安全性的III期头对头研究。
J Clin Med. 2024 May 31;13(11):3262. doi: 10.3390/jcm13113262.
5
Night-time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole.替戈拉赞与沃诺拉赞或埃索美拉唑相比对夜间胃酸的抑制作用。
Br J Clin Pharmacol. 2022 Jul;88(7):3288-3296. doi: 10.1111/bcp.15268. Epub 2022 Feb 23.
6
Efficacy of Tegoprazan for Improving the Susceptibility of Antimicrobial Agents against Antibiotic-Resistant .替加环素改善抗菌药物对耐药. 抗菌活性的疗效。
Gut Liver. 2021 Jan 15;15(1):53-60. doi: 10.5009/gnl20247.
7
Update on the Management of Infection.感染管理的最新进展。
Curr Treat Options Gastroenterol. 2020;18(3):476-487. doi: 10.1007/s11938-020-00300-3. Epub 2020 Jul 17.
8
Randomised clinical trial: tegoprazan, a novel potassium-competitive acid blocker, or lansoprazole in the treatment of gastric ulcer.随机临床试验：替戈拉赞，一种新型钾离子竞争性酸阻滞剂，或兰索拉唑治疗胃溃疡。
Aliment Pharmacol Ther. 2020 Sep;52(5):789-797. doi: 10.1111/apt.15865. Epub 2020 Jul 23.